Patents by Inventor James G. Nadeau

James G. Nadeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5958700
    Abstract: A detector oligonucleotide having a sequence which forms an intramolecularly base-paired secondary structure is described for use in detecting nucleic acid target sequences and target sequence amplification. The detector oligonucleotide is further modified by linkage to two dyes which form a donor/acceptor dye pair. The two dyes are positioned on the detector oligonucleotide such that they are in close spatial proximity in the base-paired, folded secondary structure, thereby causing quenching of donor fluorescence. The detector oligonucleotide may optionally further comprise a restriction endonuclease recognition site (RERS) which remains partially or entirely single-stranded in the base-paired secondary structure. The RERS is flanked by the two dyes. In the presence of target, the base-paired secondary structure is unfolded or linearized, increasing the distance between the donor and acceptor dyes and causing a change in fluorescence of the donor and/or the acceptor.
    Type: Grant
    Filed: January 26, 1999
    Date of Patent: September 28, 1999
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, J. Bruce Pitner, C. Preston Linn, James L. Schram
  • Patent number: 5935791
    Abstract: Detector nucleic acids are employed for detection of nucleic acid target sequences by fluorescence quenching mechanisms. The detector nucleic acid comprises at least two oligonucleotides and is partially single-stranded and partially double-stranded. One of the two dyes of a donor/acceptor dye pair is linked to the first oligonucleotide and the other is linked to a second oligonucleotide such that they are in close spatial proximity when the first and second oligonucleotides are base-paired and donor fluorescence is quenched. A single second oligonucleotide may be hybridized to the first oligonucleotide or multiple second oligonucleotides may be hybridized to the first oligonucleotide and to each other, forming a junction structure comprising multiple donor/acceptor dye pairs. The detector oligonucleotide retains its partially single-stranded and partially double-stranded conformation in the absence of target.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: August 10, 1999
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, Helen V. Hsieh, J. Bruce Pitner, C. Preston Linn
  • Patent number: 5928869
    Abstract: A detector oligonucleotide having a sequence which forms an intramolecularly base-paired secondary structure is described for use in detecting nucleic acid target sequences and target sequence amplification. The detector oligonucleotide is further modified by linkage to two dyes which form a donor/acceptor dye pair. The two dyes are positioned on the detector oligonucleotide such that they are in close spatial proximity in the base-paired, folded secondary structure, thereby causing quenching of donor fluorescence. The detector oligonucleotide may optionally further comprise a restriction endonuclease recognition site (RERS) which remains partially or entirely single-stranded in the base-paired secondary structure. The RERS is flanked by the two dyes. In the presence of target, the base-paired secondary structure is unfolded or linearized, increasing the distance between the donor and acceptor dyes and causing a change in fluorescence of the donor and/or the acceptor.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: July 27, 1999
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, J. Bruce Pitner, C. Preston Linn, James L. Schram
  • Patent number: 5919630
    Abstract: Single-stranded signal primers are modified by linkage to two dyes which form a donor/acceptor dye pair. The two dyes are positioned in sufficiently close spatial proximity on the signal primer that the fluorescence of the first dye is quenched by the second dye. The signal primer may further comprise a restriction endonuclease recognition site (RERS) between the two dyes. As the signal primer is initially single-stranded and remains single-stranded in the absence of target, the restriction endonuclease recognition site is not cleavable or nickable by the restriction endonuclease. In the presence of target, however, signal primer and the restriction endonuclease recognition site are rendered double-stranded and cleavable or nickable by the restriction endonuclease. Cleavage or nicking separates the two dyes and a change in fluorescence due to decreased quenching is detected as an indication of the presence of the target sequence or of target sequence amplification.
    Type: Grant
    Filed: November 4, 1998
    Date of Patent: July 6, 1999
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, J. Bruce Pitner, James L. Schram, C. Preston Linn, Glenn P. Vonk, G. Terrance Walker
  • Patent number: 5888739
    Abstract: G-quartet structures have been found to be useful in fluorescence assays to detect a selected nucleic acid sequence. When oligonucleotides containing these structures are labeled with a donor fluorophore and an acceptor dye, the folding or interaction of the oligonucleotides in the G-quartet structure brings the donor-acceptor pair into close proximity, allowing an interaction between the two labels which results in quenching of donor fluorescence or a change in other fluorescence properties which are the result of the interaction of two dyes in close proximity. The G-quartet structure unfolds or is otherwise disrupted upon hybridization to its complementary sequence, increasing the distance between the two dye labels. This results in decreased donor quenching or a change in another proximity-related fluorescence parameter.
    Type: Grant
    Filed: September 9, 1997
    Date of Patent: March 30, 1999
    Assignee: Becton, Dickinson and Company
    Inventors: J. Bruce Pitner, James G. Nadeau, Glenn P. Vonk
  • Patent number: 5882870
    Abstract: The present invention relates to a system for the reversible anticoagulation of blood utilizing a nucleic acid ligand which binds thrombin and a reversing agent which has greater affinity for the nucleic acid ligand than does thrombin. When used with a blood sample, the nucleic acid ligand binds thrombin, preventing it from converting fibrinogen to fibrin, and thus anticoagulating the blood. Subsequently, the reversing agent may be added to the anticoagulated blood sample, and by competitive binding, replaces thrombin bound to the ligand, thus freeing the thrombin to convert fibrinogen to fibrin and allowing the blood to coagulate.
    Type: Grant
    Filed: January 14, 1998
    Date of Patent: March 16, 1999
    Assignee: Becton Dickinson and Company
    Inventors: James G. Nadeau, Erwin A. Vogler
  • Patent number: 5846726
    Abstract: Single-stranded signal primers are modified by linkage to two dyes which form a donor/acceptor dye pair. The two dyes are positioned in sufficiently close spatial proximity on the signal primer that the fluorescence of the first dye is quenched by the second dye. The signal primer may further comprise a restriction endonuclease recognition site (RERS) between the two dyes. As the signal primer is initially single-stranded and remains single-stranded in the absence of target, the restriction endonuclease recognition site is not cleavable or nickable by the restriction endonuclease. In the presence of target, however, signal primer and the restriction endonuclease recognition site are rendered double-stranded and cleavable or nickable by the restriction endonuclease. Cleavage or nicking separates the two dyes and a change in fluorescence due to decreased quenching is detected as an indication of the presence of the target sequence or of target sequence amplification.
    Type: Grant
    Filed: May 13, 1997
    Date of Patent: December 8, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, J. Bruce Pitner, James L. Schram, C. Preston Linn, Glenn P. Vonk, G. Terrance Walker
  • Patent number: 5840487
    Abstract: Methods employing internal oligonucleotide standards in isothermal nucleic acid amplification reactions to determine the efficacy of the amplification reaction and to quantify pre-amplification target levels.
    Type: Grant
    Filed: February 18, 1997
    Date of Patent: November 24, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, Michael C. Little
  • Patent number: 5811269
    Abstract: Primers and methods for adapter-mediated multiplex amplification of the IS6110 insertion element of the Mycobacterium tuberculosis (M.tb) complex and a 16S rDNA target common to essentially all mycobacteria are described. In certain embodiments, the primers are optimized for efficient multiplex amplification in thermophilic SDA. The multiplex Strand Displacement Amplification methods of the invention are capable, in a single amplification reaction, of simultaneously identifying M. tuberculosis and providing a screen for substantially all of the clinically relevant species of mycobacteria. Also disclosed are internal control sequences designed for coamplification with the two targets, allowing assessment of amplification efficiency and/or quantitation of the targets.
    Type: Grant
    Filed: April 30, 1996
    Date of Patent: September 22, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, Cheryl H. Dean, James L. Schram, Deborah R. Howard, Margaret S. Dey, David J. Wright
  • Patent number: 5736365
    Abstract: Primers and methods for adapter-mediated multiplex amplification of the IS6110 insertion element of Mycobacterium tuberculosis (M.tb) and the 16S ribosomal gene of Mycobacterium tuberculosis, useful for simultaneously detecting and/or identifying species of the M. tuberculosis complex and other clinically relevant Mycobacterium species. Multiplex Strand Displacement Amplification (SDA) is used in a single amplification reaction which is capable of simultaneously identifying M. tuberculosis and providing a screen for substantially all of the clinically relevant species of Mycobacteria. Also disclosed are methods for adapter-mediated multiplex amplification of multiple target sequences and a single internal control sequence for determination of sample efficacy or quantitation of the targets.
    Type: Grant
    Filed: August 29, 1996
    Date of Patent: April 7, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: George Terrance Walker, James G. Nadeau, Patricia Anne Spears, Colleen M. Nycz, Daryl Dee Shank, James L. Schram, Stewart Russel Jurgensen
  • Patent number: 5723296
    Abstract: Methods for identification or detection of a species of an organism or a group of related species of an organism by species non-specific amplification of a target sequence followed by species- or group-specific detection of the amplification products. Also provided are a target sequence which is amplifiable in multiple species of mycobacteria using a single pair of amplification primers and species- and group-specific detector probes for hybridization to the assay regioin of the amplified target. Blocking oligonucleotides are employed to allow discrimination among species in which the amplified target sequences are sufficiently similar that they cross-hybridize to an assay probe.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: March 3, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: Colleen Marie Nycz, James G. Nadeau, Patricia Brinkley Scott, Daryl Dee Shank, Patricia Anne Spears
  • Patent number: 5691145
    Abstract: Oligonucleotides which form G-quartet structures have been found to be useful in fluorescence assays to detect a selected nucleic acid sequence. When one end of the oligonucleotide is labeled with a donor fluorophore and the other end is labeled with an acceptor dye, the folding of the molecule in the G-quartet structure brings the donor-acceptor pair into close proximity, allowing an interaction between the two labels which results in quenching of donor fluorescence or a change in other fluorescence properties which are the result of the interaction of two dyes in close proximity. The G-quartet structure unfolds upon hybridization to its complementary sequence, increasing the distance between the two dye labels. This results in decreased donor quenching or a change in another proximity-related fluorescence parameter. The associated increase in donor fluorescence intensity or the change in another fluorescence parameter may be monitored as an indication of the presence of a selected nucleic acid sequence.
    Type: Grant
    Filed: August 27, 1996
    Date of Patent: November 25, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: J. Bruce Pitner, Glenn P. Vonk, James G. Nadeau
  • Patent number: 5681705
    Abstract: Amplification primers and methods are disclosed for complex-specific amplification of target sequences in the dnaJ genes of the Mycobacterium Avium Complex species. Also provided are assay probes for detection of the amplification products and/or identification of the MAC species which is present.
    Type: Grant
    Filed: August 28, 1995
    Date of Patent: October 28, 1997
    Inventors: James L. Schram, James G. Nadeau, Cheryl H. Dean
  • Patent number: 5668265
    Abstract: The present invention relates to bi-directional nucleic acid ligand compounds wherein at least two oligonucleotides of opposite sequence polarity are linked to a connecting compound at their same respective terminii; either the 5' terminii or the 3 ' terminii. These compounds are useful for binding protein or small molecule targets and thus may be used as diagnostic or therapeutic agents.
    Type: Grant
    Filed: March 12, 1996
    Date of Patent: September 16, 1997
    Assignee: Becton Dickinson and Company
    Inventors: James G. Nadeau, Mary Lee Ciolkowski, Erwin A. Vogler
  • Patent number: 5658738
    Abstract: The present invention relates to bi-directional nucleic acid ligand compounds wherein at least two oligonucleotides of opposite sequence polarity are linked to a connecting compound at their same respective terminii; either the 5' terminii or the 3' terminii. These compounds are useful for binding protein or small molecule targets and thus may be used as diagnostic or therapeutic agents.
    Type: Grant
    Filed: December 11, 1995
    Date of Patent: August 19, 1997
    Assignee: Becton Dickinson and Company
    Inventors: James G. Nadeau, Mary Lee Ciolkowski, Erwin A. Vogler
  • Patent number: 5624825
    Abstract: Methods for multiplex amplification of target nucleic acid sequences using a single pair of primers. Defined sequences are appended to the ends of multiple target sequences as part of the amplification reaction so that no steps in addition to amplification are required. The target sequences with the appended defined sequences need not be isolated prior to amplification. In one embodiment for coamplification of two target sequences, a sequence corresponding to a terminal segment of the first target sequence is appended to one end of the second target sequence and a sequence corresponding to a terminal segment of the second target sequence is appended to one end of the first target sequence. Amplification of the two targets then requires only a single pair of primers. Alternatively, a single defined sequence may be appended to the 5' and 3' ends of any number of selected targets. All such modified target sequences may then be amplified using a single pair of primers which hybridize to the defined end-sequences.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: April 29, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: George T. Walker, James G. Nadeau, Michael C. Little
  • Patent number: 5593867
    Abstract: Fluorescence polarization methods for detection of nucleic acid amplification. A fluorescently labelled oligodeoxynucleotide probe is converted from single- to double-stranded form in a target dependent manner during amplification of the target sequence. This conformational change is accompanied by an increase in fluorescence polarization values. The increase in fluorescence polarization can be measured on a transient-state fluorometer in real-time during the amplification reaction without any physical manipulation of the sample. The inventive methods therefore provide a closed, homogeneous system for both amplification of target sequences and detection of amplification. Alternatively, amplification may be detected in the fluorometer after the amplification reaction is completed.
    Type: Grant
    Filed: September 23, 1994
    Date of Patent: January 14, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: G. Terrance Walker, James G. Nadeau, C. Preston Linn
  • Patent number: 5561044
    Abstract: Primers and methods for adapter-mediated multiplex amplification of the IS6110 insertion element of Mycobacterium tuberculosis (M.tb) and the 16S ribosomal gene of Mycobacterium tuberculosis, useful for simultaneously detecting and/or identifying species of the M. tuberculosis complex and other clinically relevant Mycobacterium species. Multiplex Strand Displacement Amplification (SDA) is used in a single amplification reaction which is capable of simultaneously identifying M. tuberculosis and providing a screen for substantially all of the clinically relevant species of Mycobacteria. Also disclosed are methods for adapter-mediated multiplex amplification of multiple target sequences and a single internal control sequence for determination of sample efficacy or quantitation of the targets.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: October 1, 1996
    Assignee: Becton, Dickinson and Company
    Inventors: George T. Walker, James G. Nadeau, Patricia A. Spears, Colleen M. Nycz, Daryl D. Shank, James L. Schram, Stewart R. Jurgensen
  • Patent number: 5547861
    Abstract: Methods for detecting, immobilizing or localizing primer extension products of a Strand Displacement Amplification reaction which are coupled to, and an indication of, amplification of the target sequence. The primer extension products are secondary, target-specific DNA products generated concurrently with SDA of the target sequence and can therefore be used to detect and/or measure target sequence amplification in real-time. In general, the secondary amplification products are not amplifiable and remain inert in the SDA reaction after they are formed without interfering with amplification of the target sequence. The secondary amplification products may be designed or modified to contain special features to facilitate their detection, immobilization or localization.
    Type: Grant
    Filed: April 18, 1994
    Date of Patent: August 20, 1996
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, George T. Walker
  • Patent number: 5470723
    Abstract: Primers and methods for adapter-mediated multiplex amplification of the IS6110 insertion element of Mycobacterium tuberculosis (M.tb) and the 16S ribosomal gene of Mycobacterium tuberculosis, useful for simultaneously detecting and/or identifying species of the M. tuberculosis complex and other clinically relevant Mycobacterium species. Multiplex Strand Displacement Amplification (SDA) is used in a single amplification reaction which is capable of simultaneously identifying M. tuberculosis and providing a screen for substantially all of the clinically relevant species of Mycobacteria. Also disclosed are methods for adapter-mediated multiplex amplification of multiple target sequences and a single internal control sequence for determination of sample efficacy or quantitation of the targets.
    Type: Grant
    Filed: August 24, 1993
    Date of Patent: November 28, 1995
    Assignee: Becton, Dickinson and Company
    Inventors: George T. Walker, James G. Nadeau, Patricia A. Spears, Colleen M. Nycz, Daryl D. Shank, James L. Schram, Stewart R. Jurgensen